Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Novo Nordisk Inc.
Current Parent Company: Novo Holdings A/S
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $3,574,209
Year: 2011
Date: June 10, 2011
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: False Claims Act and related
Violation Description: Novo Nordisk Inc. agreed to pay $3.5 million to settle multistate litigation alleging that it promoted its hemostasis management drug NovoSeven for uses not approved by the Food and Drug Administration and thus caused false claims to be submitted to state Medicaid programs. This was part of a larger $25 million settlement involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Denmark
Ownership Structure of Current Parent: privately held
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.